Síndrome de Down y enfermedad de Alzheimer: factores de riesgo, evaluación e intervención

• Díaz Pérez, Elvira ^[1] ; Gómez Sánchez, Laura E. ^[1] ; Alcedo Rodríguez, Mª Ángeles ^[1]
  1. [1] Universidad de Oviedo

     Universidad de Oviedo

     Oviedo, España

     
• Localización: Revista Española de Discapacidad (REDIS), ISSN-e 2340-5104, Vol. 4, Nº. 1, 2016 (Ejemplar dedicado a: Revista española de discapacidad), págs. 27-51
• Idioma: español
• DOI: 10.5569/2340-5104.04.01.02
• Enlaces
  • Texto completo (pdf)
• Dialnet Métricas: 2 Citas
• Resumen

  • Existe una estrecha relación entre el síndrome de Down y la enfermedad de Alzheimer. Diversos factores de riesgo influyen en esta relación, en la que la evaluación de la demencia es difícil debido a la falta de instrumentos y tratamientos específicos. Se realizó una búsqueda de los años comprendidos entre 2005-2015 en diferentes bases de datos. Se identificaron diversos factores de riesgo (genéticos, ambientales, cognitivos) y se encontraron varios instrumentos de evaluación, poco adecuados y/o con debilidades psicométricas. Los tratamientos existentes son escasos y, casi exclusivamente, farmacológicos. Se discute acerca de la importancia de llevar a cabo estudios sistemáticos sobre los factores de riesgo para la prevención de la enfermedad de Alzheimer en personas con síndrome de Down, así como la necesidad de un protocolo de evaluación específico y adaptado que permita implementar tratamientos más específicos y efectivos.

• Referencias bibliográficas
  • Albert, M. y Cohen, C. (1992): “The test for severe impairment: An instrument for the assessment of patients with severe cognitive dysfunction”....
  • American Psychiatric Association (2013): Diagnostic and statistical manual of mental disorders (5ª ed.), Arlington, VA: American Psychiatric...
  • American Psychiatric Association (2000): DSM-IV-TR: Manual diagnóstico y estadístico de los trastornos mentales, Barcelona: Masson.
  • Avila, R. et al. (2007): “Neuropsychological rehabilitation in mild and moderate Alzheimer’s disease patients”. Behavioural Neurology, 18...
  • Bahar-Fuchs, A. et al. (2013): “Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer’s disease and vascular dementia”....
  • Ball, S.L. et al. (2006): “Personality and behavior changes mark the early stages of Alzheimer’s disease in adults with Down syndrome: Findings...
  • Ball, S.L. et al. (2004): “The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults...
  • Benejam, B. et al. (2015): “Patterns of performance on the Modified Cued Recall Test in Spanish adults with Down syndrome with and without...
  • Benejam, B. (2009): “Síntomas de demencia en el síndrome de Down”. Revista Médica Internacional sobre el síndrome de Down, 13 (2): 18-21.
  • Bittles, A.H. y Glasson, E.J. (2004): “Clinical, social and ethical implications of changing life expectancy in Down syndrome”. Developmental...
  • Boada-Rovira, M. et al. (2005): “Estudio clinicoterapéutico de la demencia en las personas con síndrome de Down y eficacia del donepecilo...
  • Borrel, J.M. (2012): “Cuidados de salud en el adulto con síndrome de Down”. Revista Española de Pediatría Clínica e Investigación, 68 (6):...
  • Burt, D.B. y Aylward, E.H. (2000): “Test battery for the diagnosis of dementia in individuals with intellectual disability. Working Group...
  • Burt, D.B. y Aylward, E.H. (1998): Test battery for the diagnosis of dementia in individuals with intellectual disability, Washington, D.C.:...
  • Burt, D.B. et al. (2005): “Comparing dementia diagnostic methods used with people with intellectual disabilities”. Journal of Policy and Practice...
  • Bush, A. y Beail, N. (2004): “Risk factors for dementia in people with Down syndrome: issues in assessment and diagnosis”. American Journal...
  • Catuara-Solarz, S. et al. (2015): “Principal component analysis of the effects of environmental enrichment and (-)-epigallocatechin-3-gallate...
  • Clare, L. (2011): “Intervención de la memoria en el envejecimiento y las demencias”, en Bruna, O. et al. (eds.): Rehabilitación Neuropsicológica:...
  • Clare, L. (2008): Neuropsychological rehabilitation and people with dementia, New York: Psychology Press.
  • Clare, L. et al. (2003): “Cognitive rehabilitation and cognitive training for early-stage Alzheimer’s disease and vascular dementia”. The...
  • Colcombe, S. y Kramer, A.F. (2003): “Fitness effects on the cognitive function of older adults: a meta-analytic study”. Psychological Science,...
  • Cooper, S.A. et al. (2014): “Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol...
  • Coppus, A. et al. (2006): “Dementia and mortality in person with Down’s syndrome”. Journal of Intellectual Disability Research, 50 (10): 768-...
  • Cramer, P.E. et al. (2012): “ApoE-directed therapeutics rapidly clear ß-amyloid and reverse deficits in AD mouse models”. Science, 335 (6075):...
  • Dalton, A. y Fedor, B. (1998): “Onset of dyspraxia in aging persons with Down syndrome: Longitudinal studies”. Journal of Intellectual and...
  • De Deyn et al. (2005): “Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized,...
  • De la Torre, R. et al. (2013): “Epigallocatechin-3- gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models...
  • De Vreese, L.P. et al. (2012): “Impact of dementia-derived nonpharmacological intervention procedures on cognition and behavior in older adults...
  • Deb, S. et al. (2007): “The dementia screening questionnaire for individuals with intellectual disabilities”. British Journal of Psychiatry,...
  • Dekker, A.D. et al. (2015): “Behavioural and psychological symptons of dementia in Down syndrome: Early indicators of clinical Alzheimer’s...
  • Down España (2012): Down España en la ONU con motivo del Día Mundial del Síndrome de Down (en línea). , acceso 13 de junio de 2016.
  • Esbensen, A.J. et al. (2013): “Long-term impact of parental well-being on adult outcomes and dementia status in individuals with Down syndrome”....
  • Esteba-Castillo, S. et al. (2013): “Adaptación y validación del Cambridge Examination for Mental Disorders of Older People with Down’s Syndrome...
  • Evenhuis, H.M. et al. (2007): Dementia Questionnaire for people with learning disabilities (DLD), Uk adaptation, San Antonio, TX: Harcourt...
  • Evenhuis, H.M. et al. (2000): Healthy ageing- Adults with Intellectual Disabilities: Physical Health Issues, Ginebra: World Health Organization.
  • Evenhuis, H.M. et al. (1990): Dementia Questionnaire for Mentally Retarded Persons, Zwammerdam: Hooge Burch.
  • Farriols, C. (2012): “Aspectos específicos del envejecimiento en el síndrome de Down”. Revista Médica Internacional sobre el Síndrome de Down,...
  • Felstrom, A. et al. (2005): “Refining diagnoses: applying the DC-LD to an Irish population with intellectual disability”. Journal of Intellectual...
  • Fernández-Ríos, L. y Buela-Casal, G. (2009): “Standards for the preparation and writing of Psychology review articles”. International Journal...
  • Finlay, W.M. y Lyons, E. (2001): “Methodological issues in interviewing and using self-report questionnaires with people with mental retardation”....
  • Fischer, A. (2016): Environmental enrichment as a method to improve cognitive function. What can we learn from animal models? (en línea)....
  • Flórez, J. (2010): “Enfermedad de Alzheimer y síndrome de Down”. Revista síndrome de Down, 27: 63-76.
  • Flórez, J. et al. (2015): “El envejecimiento en las personas con síndrome de Down”, en Flórez, J. et al. (coords.): Síndrome de Down: Neurobiología,...
  • Garvía, B. (2014): Trastornos mentales en el síndrome de Down (en línea). < http://www. sindromedownvidaadulta.org/revista-de-adultos-n-17-junio-2014/articulos-no17/...
  • Gedye, A. (1995): Dementia Scale for Down Syndrome, Vancouver, BC: Gedye Research and Consulting.
  • Ghezzo, A. et al. (2014): “Age-related changes of adaptive and neuropsychological features in persons with Down syndrome”. Plos One, 9 (11):...
  • Glasson, E.J. et al. (2014): “The triple challenges associated with age-relates comorbidities in Down syndrome”. Journal of Intellectual Disability...
  • Hanney, M. et al. (2012): “Memantine for dementia in adults older than 40 years with Down’s syndrome (MEADOWS): a randomized, double-blind,...
  • Hanney, M.L. et al. (2009): “Overview of the Neuropshychological assessment of dementia and intellectual disability”, en Prasher, V.P. (ed.):...
  • Hartley, D. et al. (2015): “Down syndrome and Alzheimer’s disease: Common pathways, common goals”. Alzheimer and Dementia, 11: 700-709.
  • Haxby, J.V. (1989): “Neuropsychological evaluation of adults with Down syndrome: Patterns of selective impairment in adults non-demented old...
  • Hayn, M. et al. (1996): “Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down’s syndrome...
  • He, G. et al. (2010): “Gamma-secretase activating protein is a therapeutic target for Alzheimer’s disease”. Nature, 467 (7311): 95-98.
  • Head, E. et al. (2012): “Aging and Down syndrome”. Current gerontology and Geriatrics Research, 2012: 1-6.
  • Hermans, H. y Evenhuis, H.M. (2014): “Multimorbidity in older adults with intellectual disabilities”. Research in Developmental Disabilities,...
  • Holland, A.J. (1995): “Down’s syndrome and the links with Alzheimer’s disease”. Journal of Neurology Neurosurgery and Psychiatry, 59: 111-114.
  • Holland, A.J. y Ball, S.L. (2009): “The Cambridge Examination for Mental Disorders of older people with Down Syndrome and Others with Intellectual...
  • Hoshino, T. et al. (2002): “Gene dose effect of the APOE-epsilon4 allele on plasma HDL cholesterol level in patients with Alzheimer’s disease”....
  • Isbir, T. et al. (2001): “Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer’s disease”. American Jounal of Alzheimer’s Disease...
  • Isobe, Y. et al. (2009): “Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate”. Internal...
  • Jankowsky, J.L. et al. (2005): “Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer’s disease”. Journal of...
  • Jones, E.L. et al. (2013): “Evidence that PICALM affects age at onset of Alzheimer’s dementia in Down syndrome”. Neurobiology of Aging, 34...
  • Jozsvai, E. et al. (2009): “Dementia Scale for Down Syndrome”, en Prasher, V.P. (ed.): Neuropsychological assessments of dementia in Down...
  • Kalsy-Lillico, S. (2014): “Living life with dementia: Enhancing Psychological wellbeing”, en Watchman, K. (ed.): Intellectual Disability and...
  • Kalsy-Lillico, S. et al. (2012): “Older adults with intellectual disability: Issues in ageing and dementia”, en Emerson, E. et al. (eds.):...
  • Key, A.P. y Dykens, E.M. (2014): “Event-related potential index of age-related differences in memory processes in adults with Down syndrome”....
  • Krinsky-McHale, S.J. et al. (2008): “Selective attention deficits associated with mild cognitive impairment and early stage Alzheimer’s disease...
  • Landau, S.M. et al. (2012): “Association of lifetime cognitive engagement and low ß-amyloid deposition”. Archives of Neurology, 69 (5): 623-629.
  • Launer, L.J. et al. (2001): “Cholesterol and neuropathologic markers of AD: a population-based autopsy study”. Neurology, 57 (8): 1447-1452.
  • Lesko, L.J. y Atkinson, A.J. (2001): “Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria,...
  • Loane, M. et al. (2013): “Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and...
  • López-Locanto, O. (2015): “Tratamiento farmacológico de la enfermedad de Alzheimer y otras demencias”. Archivos de Medicina Interna, 37 (1):...
  • Lott, I.T. y Head, E. (2001): “Down syndrome and Alzheimer’s disease: a link between development and aging”. Mental Retardation and Developmental...
  • Malea-Fernández, I. et al. (2014): “Neurología y Síndrome de Down. Desarrollo y atención temprana”. Revista Española de Pediatría, 68 (6):...
  • Mascarenhas-Fonseca, L. et al. (2015): “Cognitive rehabilitation of dementia in adults with Down syndrome: a review of non-pharmacological...
  • Mausner, J.S. y Kramer, S. (1985): Mausner and Bahn epidemiology: an introductory text, Philadelphia, PA: W.B. Saunders.
  • Mawuenyega, K.G. et al. (2010): “Decreased clearance of CNS beta-amyloid in Alzheimer’s disease”. Science, 330 (6012): 1774-1776.
  • McCarron, M. et al. (2005): “Health co-morbidities in ageing persons with Down syndrome and Alzheimer’s dementia”. Journal of Intellectual...
  • McGuire, B.E. et al. (2006): “Alzheimer’s disease in Down syndrome and intellectual disability: A review”. Irish Journal of Psychology, 27...
  • Moceri, V.M. et al. (2001): “Using census data and birth certificates to reconstruct the early-life socioeconomic environment and the relation...
  • Mohan, M. et al. (2009a): “Galantamine for dementia in people with Down syndrome”. The Cochrane Database of Systematic Reviews, 21 (1): CD007656.
  • Mohan, M. et al. (2009b): “Rivastigmine for dementia in people with Down syndrome”. The Cochrane Database of Systematic Reviews, 21 (1): CD007658.
  • Moran, J.A. et al. (2013): “The National Task Group on Intellectual Disabilities and Dementia Practices consensus recommendations for the...
  • Muchova, J. et al. (2014): “Oxidative stress and Down syndrome. Do antioxidants play a role in therapy?”. Physiological Research, 63: 535-...
  • Mullins, D. et al. (2013): “Dementia in Down’s syndrome: an MRI comparison with Alzheimer’s disease in the general population”. Journal of...
  • Mulryan, N.M. et al. (2009): “The test for Severe Impairment”, en Prasher, V.P. (ed.): Neuropsychological assessments of dementia in Down...
  • Nakamura, E. y Tanaka, S. (1998): “Biological ages of adult men and women with Down’s syndrome and its changes with aging”. Mechanisms of...
  • Neal, M. y Barton-Wright, P. (2003): “Validation therapy for dementia”. The Cochrane Database of Systematic Reviews, 3: CD001394.
  • Neal, M. y Briggs, M. (2000): “Validation therapy for dementia”. The Cochrane Database of Systematic Reviews, 2: CD001394.
  • Nieuwenhuis-Mark, R.E. (2009): “Diagnosing Alzheimer’s dementia in Down syndrome: Problems and possible solutions”. Research in Developmental...
  • O’Caoimh, R. et al. (2013): “Screening for Alzheimer’s Disease in Down’s syndrome”. Journal of Alzheimer’s Disease and Parkinsonism, S7 (001):...
  • Organización Mundial de la Salud (1992): The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research,...
  • Parajua-Pozo, J.L. y Casis-Arguea, S. (2000): “Síndrome de Down y demencia”. Revista de Neurología, 31 (2): 126-128.
  • Phillips, C. et al. (2015): “The link between physical activity and cognitive dysfunction in Alzheimer disease”. Physical Therapy, 95 (7):...
  • Prasher, V.P. (2009): “The Adaptative Behavior Dementia Questionnaire (ABDQ)”, en Prasher, V.P. (ed.): Neuropsychological assessments of dementia...
  • Prasher V.P. et al. (2004): “The adaptive Behaviour Dementia Questionnaire (ABDQ): Screening Questionnaire for dementia of Alzheimer’s disease...
  • Prasher, V.P. et al. (2003): “Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer’s disease in adults with...
  • Presson, A.P. et al. (2013): “Current estimate of Down syndrome population prevalence in the United States”. The journal of Pediatrics, 163...
  • Rabinowitz, J. et al. (2007): “Treating behavioral and psychological symptoms in patients with psychosis of Alzheimer’s disease using risperidone”....
  • Ringman, J.M. et al. (2014): “Genetic heterogeneity in Alzheimer disease and implications for treatment strategies”. Current Neurology and...
  • Ringman, J.M. et al. (2012): “Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype”. Archives...
  • Royal College of Psychiatrists (2001): DC-LD (Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/...
  • Saxton, J. et al. (1990): “Assessment of the severely impaired patient: Description and validation of a new neuropsychological test battery...
  • Schupf, N. et al. (2006): “Bioavailable estradiol and age at onset of Alzheimer’s disease in postmenopausal women with Down syndrome”. Neuroscience...
  • Schupf, N. et al. (2003): “Onset of dementia is associated with age at menopause in women with Down’s syndrome”. Annals of Neurology, 54:...
  • Schupf, N. et al. (1998): “Earlier onset of Alzheimer’s disease in men with Down syndrome”. Neurology, 50: 991-995.
  • Sekijima, Y. et al. (1998): “Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down’s syndrome”....
  • Small, J.A. (2012): “A new frontier in spaced retrieval memory training for persons with Alzheimer’s disease”. Neuropsychological Rehabilitation,...
  • Smith, D.S. (2001): “Health care management of adults with Down syndrome”. American Family Physician, 64: 1031-1038.
  • Smith, P.J. et al. (2010): “Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials”. Psychomatic...
  • Spector, A. et al. (2000): “Reality orientation for dementia”. The Cochrane Database of Systematic Reviews, 4: CD001119.
  • Stancliffe, R. et al. (2012): “Demographic Characteristics, Health Conditions, and Residential Service Use in Adults with Down Syndrome in...
  • Strydom, A. y Hassiotis, A. (2003): “Diagnostic instruments for dementia in older people with intellectual disability in clinical practice”....
  • Strydom, A.et al. (2013a): “Incidence of dementia in older adults with intellectual disabilities”. Research in Developmental Disabilities,...
  • Strydom, A. et al. (2013b): “Validity of criteria for dementia in older people with intellectual disability”. The American Journal of Geriatric...
  • Strydom, A. et al. (2010): “Dementia in older adults with intellectual disabilities – Epidemiology, presentation, and diagnosis”. Journal...
  • Strydom, A. et al. (2007): “Prevalence of dementia in intellectual disability using different diagnostic criteria”. The British Journal of...
  • Subirana-Mirete, J. et al. (2011): “Demencias y enfermedad de Alzheimer”, en Bruna, O. et al. (eds.): Rehabilitación neuropsicológica: intervención...
  • Temple, V. et al. (2001): “Alzheimer’s dementia in Down’s syndrome: the relevance of cognitive ability”. Journal of Intellectual Disability...
  • Tsao, R. et al. (2015): “Variability of the Aging Process in Dementia-Free Adults with Down syndrome”. American Journal of Intellectual and...
  • Tyrrell, J. et al. (2001): “Dementia in people with Down’s syndrome”. International Journal of Geriatric Psychiatry, 16: 1168-1174.
  • Tyrrell, J. et al. (1996): “Dementia in an Irish population of Down syndrome people”. Irish Journal of Psychological Medicine, 13 (2): 51-54.
  • Van der Flier, W.M. (2005): “Epidemiology and risk factors of dementia”. Journal of Neurology, Neurosurgery and Psychiatry, 76 (5): 2-7.
  • Weksler, M.E. et al. (2013): “Alzheimer’s disease and Down’s syndrome: treating two paths to dementia”. Autoinmunity Reviews, 12: 670- 673.
  • Woods, R.T. (2002): “Reality orientation: a welcome return?” Age and ageing, 31 (3): 155- 156.
  • Woods, R.T. (1999): “Psychological therapies in dementia”, en Woods, R.T. (ed.): Psychological problems of aging: assessment, treatment and...
  • Woods, B. et al. (2005): “Reminiscence therapy for dementia”. The Cochrane Database of Systematic Reviews,18 (2): CD001120.
  • Zeilinger, E.L. et al. (2013a): “CAPs-IDD: Characteristics of assessment instruments for psychiatric disorders in persons with intellectual...
  • Zeilinger, E.L. et al. (2013b): “A systematic review on assessment instruments for dementia in persons with intellectual disabilities”. Research...
  • Zigman, W.B. y Lott, I.T. (2007): “Alzheimer’s disease in Down syndrome: Neurobiology and risk”. Mental Retardation and Developmental Disabilities...